Medicine
M. Bassetti, A. di Biagio, G. Cenderello, V. Del Bono, A. Palermo, L. Molfetta, F. Pipino, D. Bassetti
tlooto Summary
Linezolid, the first approved oxazolidinone, appears to be a promising new agent for the treatment of serious gram-positive infections, particularly when other therapeutic approaches are not feasible or a long-term antibiotic therapy is required.
Abstract
Abstract is not available.
Citation format
BASSETTI, M., et al. Linezolid treatment of prosthetic hip infections due to methicillin-resistant staphylococcus aureus (MRSA). Journal of Orthopaedics and Traumatology, 2000, 1: 147–150.